Abstract

The receptor activator of NF-kappaB (RANK) belongs to the neuregulin/tumor necrosis factor (TNF) receptor superfamily and is activated by RANK ligand (RANK-L), a homotrimeric, TNF-like cytokine. RANK is present on the surface of osteoclast cell precursors, where its interaction with RANK-L induces their terminal differentiation into osteoclasts, thus increasing bone breakdown. The secreted, soluble receptor osteoprotegerin (OPG) interrupts this activation by binding directly to RANK-L. Therefore, osteoclast maturation (and bone homeostasis) is regulated in vivo by OPG levels of expression. We have studied the assembly state and affinity of OPG for RANK-L by sedimentation analyses and surface plasmon resonance (Biacore). Full-length, homodimeric OPG binds to RANK-L with a KD of 10 nM. OPG is also a member of the TNF receptor superfamily and contains four disulfide-rich ligand-binding domains, yet lacks a transmembrane region separating the ligand-binding region from the two death domains, as observed for other receptor family members. We showed that dimerization of OPG results from noncovalent interactions mediated by the death domains and to a lesser extent by a C-terminal heparin-binding region. In contrast, a C-terminal intermolecular disulfide bond does not contribute to the formation or stability of OPG dimers. A truncate of osteoprotegerin, containing the ligand-binding domains but lacking the dimerization domains, bound RANK-L with a KD of approximately 3 microM, indicating that monomer oligomerization for the OPG provides an increase of 3 orders of magnitude in the affinity for RANK-L. Therefore, OPG dimer formation is required for the mechanism of inhibition of the RANK-L/RANK receptor interaction.

Highlights

  • Receptor activator of NF-␬B ligand (RANK-L)3 is a tumor necrosis factor (TNF) ligand superfamily member [6, 7]

  • OPG is a TNF receptor (TNFR) family secreted, soluble homodimeric receptor (50-kDa monomer) composed of four N-terminal cysteine-rich domains (CRDs), followed by two modules homologous to the death domains (DDs) of the TNFR that are extracellular because OPG lacks a transmembrane domain [21]

  • The kinetics of RANK ligand (RANK-L) binding to osteoprotegerin-IgG Fc domain fusion (OPG-Fc) captured on a protein A/G/CM5 surface was measured over a 2.5 order of magnitude concentration range of RANK-L

Read more

Summary

MATERIALS AND METHODS

Production of Recombinant Viruses and Protein Expression—All constructs were prepared using the pFastBac (pFB; Invitrogen) expression vector. Sedimentation equilibrium analysis was performed using two-channel Epon centerpieces with quartz windows, spinning at 25,000, 30,000, and 35,000 rpm for RANK-L; 16,000 and 20,000 for OPG-H; 16,000, 20,000, and 24,000 rpm for OPG⌬B-H; 24,000 and 29,000 rpm for OPG⌬DDB-H; 20,000, 24,000, and 30,000 rpm for OPG⌬CRD-H; 8,000, 11,000, and 14,000 rpm for OPGC400A-H; 8,000 or 9,000 and 12,000 rpm for OPG-Fc; and formed complexes. Assays to measure OPG-Fc binding to RANK-L used a CM5 carboxymethyl-dextran sensor chip with protein A/G (Pierce) immobilized via amine coupling at 500 RUs per flow cell. Biacore assays for binding of the His6-tagged wild type OPG and its truncates were done using a CM5 sensor chip with C ϩ RANK-L immobilized through its free cysteine residues. Global analysis of at least six concentrations around the KD was performed using BiaEvaluation 3.1 using a 1:1 Langmuir model for the association (Equation 1)

RESULTS
Summary
O-H: 2 R
OCA: 2 R
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call